"sample_name"	"unique_patient_ID"	"alt_sample_name"	"sample_type"	"primarysite"	"summarygrade"	"G"	"summarystage"	"T"	"N"	"M"	"age_at_initial_pathologic_diagnosis"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"os_binary"	"relapse_binary"	"family_history"	"msi"	"location"	"summarylocation"	"gender"	"kras"	"braf"	"line1"	"tumor_size"	"mss"	"mutation_apc"	"lymphnodesremoved"	"lymphnodesinvaded"	"stageall"	"ethnicity"	"dfs_status"	"days_to_recurrence_or_death"	"batch"	"drug_name"	"drug_treatment"	"drug_response"	"uncurated_author_metadata"	"fu"	"bevacizumab"	"irinotecan"	"capecitabine"	"cpt11"	"dexamethasone"	"erbitux"	"gcsf"	"fudr"	"folfiri"	"folfox"	"leucovorin"	"mitomycin"	"platin"	"panitumumab"	"pegfilgrastim"	"raltitrexed"	"xeloda"	"ancillary"	"chemotherapy"	"moltherapy"
"GSM712398"	NA	"colorectal cancer sample AUS2_003_p348 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-05"	NA	NA	NA	"title: colorectal cancer sample AUS2_003_p348 [gene-level]///geo_accession: GSM712398///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 2.6///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712398/GSM712398_AUS2_003_p348_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712398/GSM712398_AUS2_003_p348_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712573 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712399"	NA	"colorectal cancer sample AUS2_010_p1622 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-07-14"	NA	NA	NA	"title: colorectal cancer sample AUS2_010_p1622 [gene-level]///geo_accession: GSM712399///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.97///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712399/GSM712399_AUS2_010_p1622_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712399/GSM712399_AUS2_010_p1622_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712574 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712400"	NA	"colorectal cancer sample AUS2_011_p423 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-01-09"	NA	NA	NA	"title: colorectal cancer sample AUS2_011_p423 [gene-level]///geo_accession: GSM712400///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.96///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712400/GSM712400_AUS2_011_p423_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712400/GSM712400_AUS2_011_p423_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712575 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712401"	NA	"colorectal cancer sample AUS2_012_p336 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-05"	NA	NA	NA	"title: colorectal cancer sample AUS2_012_p336 [gene-level]///geo_accession: GSM712401///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.95///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712401/GSM712401_AUS2_012_p336_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712401/GSM712401_AUS2_012_p336_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712576 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712402"	NA	"colorectal cancer sample AUS2_013_p874 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-05"	NA	NA	NA	"title: colorectal cancer sample AUS2_013_p874 [gene-level]///geo_accession: GSM712402///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.94///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712402/GSM712402_AUS2_013_p874_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712402/GSM712402_AUS2_013_p874_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712577 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712403"	NA	"colorectal cancer sample AUS2_017_p296 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-28"	NA	NA	NA	"title: colorectal cancer sample AUS2_017_p296 [gene-level]///geo_accession: GSM712403///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.76///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712403/GSM712403_AUS2_017_p296_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712403/GSM712403_AUS2_017_p296_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712578 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712404"	NA	"colorectal cancer sample AUS2_018_p1355 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-17"	NA	NA	NA	"title: colorectal cancer sample AUS2_018_p1355 [gene-level]///geo_accession: GSM712404///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.91///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712404/GSM712404_AUS2_018_p1355_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712404/GSM712404_AUS2_018_p1355_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712579 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712405"	NA	"colorectal cancer sample AUS2_019_p312 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-22"	NA	NA	NA	"title: colorectal cancer sample AUS2_019_p312 [gene-level]///geo_accession: GSM712405///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.74///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712405/GSM712405_AUS2_019_p312_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712405/GSM712405_AUS2_019_p312_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712580 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712406"	NA	"colorectal cancer sample AUS2_022_p452 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-05"	NA	NA	NA	"title: colorectal cancer sample AUS2_022_p452 [gene-level]///geo_accession: GSM712406///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 4.65///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712406/GSM712406_AUS2_022_p452_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712406/GSM712406_AUS2_022_p452_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712581 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712407"	NA	"colorectal cancer sample AUS2_024_p280 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-05"	NA	NA	NA	"title: colorectal cancer sample AUS2_024_p280 [gene-level]///geo_accession: GSM712407///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 4.67///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712407/GSM712407_AUS2_024_p280_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712407/GSM712407_AUS2_024_p280_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712582 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712408"	NA	"colorectal cancer sample AUS2_026_p473 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-03-19"	NA	NA	NA	"title: colorectal cancer sample AUS2_026_p473 [gene-level]///geo_accession: GSM712408///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.62///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712408/GSM712408_AUS2_026_p473_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712408/GSM712408_AUS2_026_p473_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712583 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712409"	NA	"colorectal cancer sample AUS2_027_p876 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-23"	NA	NA	NA	"title: colorectal cancer sample AUS2_027_p876 [gene-level]///geo_accession: GSM712409///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.17///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712409/GSM712409_AUS2_027_p876_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712409/GSM712409_AUS2_027_p876_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712584 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712410"	NA	"colorectal cancer sample AUS2_028_p256 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-28"	NA	NA	NA	"title: colorectal cancer sample AUS2_028_p256 [gene-level]///geo_accession: GSM712410///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.59///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712410/GSM712410_AUS2_028_p256_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712410/GSM712410_AUS2_028_p256_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712585 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712411"	NA	"colorectal cancer sample AUS2_029_p476 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-01-09"	NA	NA	NA	"title: colorectal cancer sample AUS2_029_p476 [gene-level]///geo_accession: GSM712411///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 3.83///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712411/GSM712411_AUS2_029_p476_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712411/GSM712411_AUS2_029_p476_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712586 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712412"	NA	"colorectal cancer sample AUS2_030_p340 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-21"	NA	NA	NA	"title: colorectal cancer sample AUS2_030_p340 [gene-level]///geo_accession: GSM712412///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.56///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712412/GSM712412_AUS2_030_p340_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712412/GSM712412_AUS2_030_p340_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712587 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712413"	NA	"colorectal cancer sample AUS2_031_p478 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-29"	NA	NA	NA	"title: colorectal cancer sample AUS2_031_p478 [gene-level]///geo_accession: GSM712413///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 2.42///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712413/GSM712413_AUS2_031_p478_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712413/GSM712413_AUS2_031_p478_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712588 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712414"	NA	"colorectal cancer sample AUS2_036_p504 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-05"	NA	NA	NA	"title: colorectal cancer sample AUS2_036_p504 [gene-level]///geo_accession: GSM712414///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.04///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712414/GSM712414_AUS2_036_p504_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712414/GSM712414_AUS2_036_p504_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712589 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712415"	NA	"colorectal cancer sample AUS2_037_p304 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-22"	NA	NA	NA	"title: colorectal cancer sample AUS2_037_p304 [gene-level]///geo_accession: GSM712415///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.47///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712415/GSM712415_AUS2_037_p304_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712415/GSM712415_AUS2_037_p304_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712590 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712416"	NA	"colorectal cancer sample AUS2_038_p249 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-22"	NA	NA	NA	"title: colorectal cancer sample AUS2_038_p249 [gene-level]///geo_accession: GSM712416///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.47///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712416/GSM712416_AUS2_038_p249_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712416/GSM712416_AUS2_038_p249_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712591 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712417"	NA	"colorectal cancer sample AUS2_041_p260 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-21"	NA	NA	NA	"title: colorectal cancer sample AUS2_041_p260 [gene-level]///geo_accession: GSM712417///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.22///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712417/GSM712417_AUS2_041_p260_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712417/GSM712417_AUS2_041_p260_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712592 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712418"	NA	"colorectal cancer sample AUS2_042_p506 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-21"	NA	NA	NA	"title: colorectal cancer sample AUS2_042_p506 [gene-level]///geo_accession: GSM712418///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 1.95///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712418/GSM712418_AUS2_042_p506_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712418/GSM712418_AUS2_042_p506_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712593 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712419"	NA	"colorectal cancer sample AUS2_043_p1327 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-22"	NA	NA	NA	"title: colorectal cancer sample AUS2_043_p1327 [gene-level]///geo_accession: GSM712419///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.81///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712419/GSM712419_AUS2_043_p1327_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712419/GSM712419_AUS2_043_p1327_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712594 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712420"	NA	"colorectal cancer sample AUS2_044_p268 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-28"	NA	NA	NA	"title: colorectal cancer sample AUS2_044_p268 [gene-level]///geo_accession: GSM712420///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.35///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712420/GSM712420_AUS2_044_p268_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712420/GSM712420_AUS2_044_p268_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712595 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712421"	NA	"colorectal cancer sample AUS2_048_p344 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-23"	NA	NA	NA	"title: colorectal cancer sample AUS2_048_p344 [gene-level]///geo_accession: GSM712421///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.08///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712421/GSM712421_AUS2_048_p344_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712421/GSM712421_AUS2_048_p344_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712596 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712422"	NA	"colorectal cancer sample AUS2_050_p533 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-03-19"	NA	NA	NA	"title: colorectal cancer sample AUS2_050_p533 [gene-level]///geo_accession: GSM712422///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.33///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712422/GSM712422_AUS2_050_p533_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712422/GSM712422_AUS2_050_p533_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712597 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712423"	NA	"colorectal cancer sample AUS2_051_p1596 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-17"	NA	NA	NA	"title: colorectal cancer sample AUS2_051_p1596 [gene-level]///geo_accession: GSM712423///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.97///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712423/GSM712423_AUS2_051_p1596_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712423/GSM712423_AUS2_051_p1596_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712598 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712424"	NA	"colorectal cancer sample AUS2_053_p328 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-22"	NA	NA	NA	"title: colorectal cancer sample AUS2_053_p328 [gene-level]///geo_accession: GSM712424///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 0.83///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712424/GSM712424_AUS2_053_p328_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712424/GSM712424_AUS2_053_p328_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712599 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712425"	NA	"colorectal cancer sample AUS2_054_p272 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-21"	NA	NA	NA	"title: colorectal cancer sample AUS2_054_p272 [gene-level]///geo_accession: GSM712425///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.1///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712425/GSM712425_AUS2_054_p272_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712425/GSM712425_AUS2_054_p272_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712600 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712426"	NA	"colorectal cancer sample AUS2_055_p536 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-15"	NA	NA	NA	"title: colorectal cancer sample AUS2_055_p536 [gene-level]///geo_accession: GSM712426///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.28///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712426/GSM712426_AUS2_055_p536_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712426/GSM712426_AUS2_055_p536_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712601 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712427"	NA	"colorectal cancer sample AUS2_058_p538 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-21"	NA	NA	NA	"title: colorectal cancer sample AUS2_058_p538 [gene-level]///geo_accession: GSM712427///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.52///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712427/GSM712427_AUS2_058_p538_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712427/GSM712427_AUS2_058_p538_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712602 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712428"	NA	"colorectal cancer sample AUS2_065_p551 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-28"	NA	NA	NA	"title: colorectal cancer sample AUS2_065_p551 [gene-level]///geo_accession: GSM712428///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 4.17///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712428/GSM712428_AUS2_065_p551_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712428/GSM712428_AUS2_065_p551_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712603 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712429"	NA	"colorectal cancer sample AUS2_068_p564 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-28"	NA	NA	NA	"title: colorectal cancer sample AUS2_068_p564 [gene-level]///geo_accession: GSM712429///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 4.13///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712429/GSM712429_AUS2_068_p564_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712429/GSM712429_AUS2_068_p564_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712604 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712430"	NA	"colorectal cancer sample AUS2_070_p566 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-28"	NA	NA	NA	"title: colorectal cancer sample AUS2_070_p566 [gene-level]///geo_accession: GSM712430///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 2.54///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712430/GSM712430_AUS2_070_p566_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712430/GSM712430_AUS2_070_p566_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712605 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712431"	NA	"colorectal cancer sample AUS2_072_p590 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-15"	NA	NA	NA	"title: colorectal cancer sample AUS2_072_p590 [gene-level]///geo_accession: GSM712431///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 4.11///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712431/GSM712431_AUS2_072_p590_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712431/GSM712431_AUS2_072_p590_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712606 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712432"	NA	"colorectal cancer sample AUS2_075_p595 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-21"	NA	NA	NA	"title: colorectal cancer sample AUS2_075_p595 [gene-level]///geo_accession: GSM712432///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 4.05///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712432/GSM712432_AUS2_075_p595_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712432/GSM712432_AUS2_075_p595_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712607 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712433"	NA	"colorectal cancer sample AUS2_084_p622 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-15"	NA	NA	NA	"title: colorectal cancer sample AUS2_084_p622 [gene-level]///geo_accession: GSM712433///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 3///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712433/GSM712433_AUS2_084_p622_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712433/GSM712433_AUS2_084_p622_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712608 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712434"	NA	"colorectal cancer sample AUS2_086_p624 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-15"	NA	NA	NA	"title: colorectal cancer sample AUS2_086_p624 [gene-level]///geo_accession: GSM712434///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.92///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712434/GSM712434_AUS2_086_p624_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712434/GSM712434_AUS2_086_p624_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712609 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712435"	NA	"colorectal cancer sample AUS2_089_p645 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-23"	NA	NA	NA	"title: colorectal cancer sample AUS2_089_p645 [gene-level]///geo_accession: GSM712435///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 2.17///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712435/GSM712435_AUS2_089_p645_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712435/GSM712435_AUS2_089_p645_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712610 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712436"	NA	"colorectal cancer sample AUS2_090_p646 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-23"	NA	NA	NA	"title: colorectal cancer sample AUS2_090_p646 [gene-level]///geo_accession: GSM712436///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712436/GSM712436_AUS2_090_p646_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712436/GSM712436_AUS2_090_p646_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712611 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712437"	NA	"colorectal cancer sample AUS2_091_p647 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-06-26"	NA	NA	NA	"title: colorectal cancer sample AUS2_091_p647 [gene-level]///geo_accession: GSM712437///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-L///characteristics_ch1.3: disease_free_survival_event: 3.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712437/GSM712437_AUS2_091_p647_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712437/GSM712437_AUS2_091_p647_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712612 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712438"	NA	"colorectal cancer sample AUS2_092_p648 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-23"	NA	NA	NA	"title: colorectal cancer sample AUS2_092_p648 [gene-level]///geo_accession: GSM712438///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.87///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712438/GSM712438_AUS2_092_p648_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712438/GSM712438_AUS2_092_p648_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712613 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712439"	NA	"colorectal cancer sample AUS2_093_p649 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-23"	NA	NA	NA	"title: colorectal cancer sample AUS2_093_p649 [gene-level]///geo_accession: GSM712439///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.7///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712439/GSM712439_AUS2_093_p649_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712439/GSM712439_AUS2_093_p649_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712614 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712440"	NA	"colorectal cancer sample AUS2_094_p640 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-21"	NA	NA	NA	"title: colorectal cancer sample AUS2_094_p640 [gene-level]///geo_accession: GSM712440///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.86///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712440/GSM712440_AUS2_094_p640_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712440/GSM712440_AUS2_094_p640_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712615 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712441"	NA	"colorectal cancer sample AUS2_096_p652 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-23"	NA	NA	NA	"title: colorectal cancer sample AUS2_096_p652 [gene-level]///geo_accession: GSM712441///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.84///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712441/GSM712441_AUS2_096_p652_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712441/GSM712441_AUS2_096_p652_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712616 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712442"	NA	"colorectal cancer sample AUS2_097_p643 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-29"	NA	NA	NA	"title: colorectal cancer sample AUS2_097_p643 [gene-level]///geo_accession: GSM712442///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.86///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712442/GSM712442_AUS2_097_p643_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712442/GSM712442_AUS2_097_p643_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712617 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712443"	NA	"colorectal cancer sample AUS2_098_p665 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-29"	NA	NA	NA	"title: colorectal cancer sample AUS2_098_p665 [gene-level]///geo_accession: GSM712443///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.85///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712443/GSM712443_AUS2_098_p665_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712443/GSM712443_AUS2_098_p665_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712618 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712444"	NA	"colorectal cancer sample AUS2_100_p668 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-06"	NA	NA	NA	"title: colorectal cancer sample AUS2_100_p668 [gene-level]///geo_accession: GSM712444///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.84///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712444/GSM712444_AUS2_100_p668_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712444/GSM712444_AUS2_100_p668_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712619 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712445"	NA	"colorectal cancer sample AUS2_114_p1356 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_114_p1356 [gene-level]///geo_accession: GSM712445///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.69///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712445/GSM712445_AUS2_114_p1356_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712445/GSM712445_AUS2_114_p1356_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712620 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712446"	NA	"colorectal cancer sample AUS2_117_p906_2 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-22"	NA	NA	NA	"title: colorectal cancer sample AUS2_117_p906_2 [gene-level]///geo_accession: GSM712446///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.67///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712446/GSM712446_AUS2_117_p906_HuEx-1_0-st-v2_2.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712446/GSM712446_AUS2_117_p906_HuEx-1_0-st-v2_2.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712621 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712447"	NA	"colorectal cancer sample AUS2_118_p907 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-29"	NA	NA	NA	"title: colorectal cancer sample AUS2_118_p907 [gene-level]///geo_accession: GSM712447///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.66///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712447/GSM712447_AUS2_118_p907_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712447/GSM712447_AUS2_118_p907_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712622 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712448"	NA	"colorectal cancer sample AUS2_119_p927 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-06"	NA	NA	NA	"title: colorectal cancer sample AUS2_119_p927 [gene-level]///geo_accession: GSM712448///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.65///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712448/GSM712448_AUS2_119_p927_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712448/GSM712448_AUS2_119_p927_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712623 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712449"	NA	"colorectal cancer sample AUS2_123_p931 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-05-29"	NA	NA	NA	"title: colorectal cancer sample AUS2_123_p931 [gene-level]///geo_accession: GSM712449///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.63///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712449/GSM712449_AUS2_123_p931_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712449/GSM712449_AUS2_123_p931_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712624 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712450"	NA	"colorectal cancer sample AUS2_127_p914 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-05-29"	NA	NA	NA	"title: colorectal cancer sample AUS2_127_p914 [gene-level]///geo_accession: GSM712450///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.58///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712450/GSM712450_AUS2_127_p914_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712450/GSM712450_AUS2_127_p914_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712625 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712451"	NA	"colorectal cancer sample AUS2_129_p934 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-06"	NA	NA	NA	"title: colorectal cancer sample AUS2_129_p934 [gene-level]///geo_accession: GSM712451///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 1.79///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712451/GSM712451_AUS2_129_p934_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712451/GSM712451_AUS2_129_p934_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712626 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712452"	NA	"colorectal cancer sample AUS2_130_p935 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-06"	NA	NA	NA	"title: colorectal cancer sample AUS2_130_p935 [gene-level]///geo_accession: GSM712452///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.44///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712452/GSM712452_AUS2_130_p935_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712452/GSM712452_AUS2_130_p935_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712627 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712453"	NA	"colorectal cancer sample AUS2_134_p949 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-06"	NA	NA	NA	"title: colorectal cancer sample AUS2_134_p949 [gene-level]///geo_accession: GSM712453///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.4///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712453/GSM712453_AUS2_134_p949_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712453/GSM712453_AUS2_134_p949_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712628 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712454"	NA	"colorectal cancer sample AUS2_140_p954 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-06"	NA	NA	NA	"title: colorectal cancer sample AUS2_140_p954 [gene-level]///geo_accession: GSM712454///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.34///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712454/GSM712454_AUS2_140_p954_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712454/GSM712454_AUS2_140_p954_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712629 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712455"	NA	"colorectal cancer sample AUS2_144_p966 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-06-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_144_p966 [gene-level]///geo_accession: GSM712455///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.27///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712455/GSM712455_AUS2_144_p966_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712455/GSM712455_AUS2_144_p966_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712630 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712456"	NA	"colorectal cancer sample AUS2_145_p977 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_145_p977 [gene-level]///geo_accession: GSM712456///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.27///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712456/GSM712456_AUS2_145_p977_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712456/GSM712456_AUS2_145_p977_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712631 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712457"	NA	"colorectal cancer sample AUS2_147_p989 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2009-06-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_147_p989 [gene-level]///geo_accession: GSM712457///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.23///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712457/GSM712457_AUS2_147_p989_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712457/GSM712457_AUS2_147_p989_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712632 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712458"	NA	"colorectal cancer sample AUS2_153_p993 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_153_p993 [gene-level]///geo_accession: GSM712458///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 0.65///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712458/GSM712458_AUS2_153_p993_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712458/GSM712458_AUS2_153_p993_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712633 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712459"	NA	"colorectal cancer sample AUS2_158_p995 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_158_p995 [gene-level]///geo_accession: GSM712459///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.11///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712459/GSM712459_AUS2_158_p995_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712459/GSM712459_AUS2_158_p995_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712634 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712460"	NA	"colorectal cancer sample AUS2_165_p1011 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-12"	NA	NA	NA	"title: colorectal cancer sample AUS2_165_p1011 [gene-level]///geo_accession: GSM712460///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: MSI-H///characteristics_ch1.3: disease_free_survival_event: 3.02///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712460/GSM712460_AUS2_165_p1011_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712460/GSM712460_AUS2_165_p1011_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712635 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712461"	NA	"colorectal cancer sample AUS2_167_p1013 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2010-03-12"	NA	NA	NA	"title: colorectal cancer sample AUS2_167_p1013 [gene-level]///geo_accession: GSM712461///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3.02///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712461/GSM712461_AUS2_167_p1013_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712461/GSM712461_AUS2_167_p1013_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712636 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712462"	NA	"colorectal cancer sample AUS2_169_p1014 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2010-03-12"	NA	NA	NA	"title: colorectal cancer sample AUS2_169_p1014 [gene-level]///geo_accession: GSM712462///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712462/GSM712462_AUS2_169_p1014_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712462/GSM712462_AUS2_169_p1014_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712637 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712463"	NA	"colorectal cancer sample AUS2_171_p1015 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"y"	NA	NA	NA	NA	NA	NA	NA	"2009-06-30"	NA	NA	NA	"title: colorectal cancer sample AUS2_171_p1015 [gene-level]///geo_accession: GSM712463///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: MSS///characteristics_ch1.3: disease_free_survival_event: 3///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712463/GSM712463_AUS2_171_p1015_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712463/GSM712463_AUS2_171_p1015_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712638 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712464"	NA	"colorectal cancer sample AUS2_175_p1471 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_175_p1471 [gene-level]///geo_accession: GSM712464///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.96///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712464/GSM712464_AUS2_175_p1471_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712464/GSM712464_AUS2_175_p1471_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712639 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712465"	NA	"colorectal cancer sample AUS2_177_p1569 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-12"	NA	NA	NA	"title: colorectal cancer sample AUS2_177_p1569 [gene-level]///geo_accession: GSM712465///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.94///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712465/GSM712465_AUS2_177_p1569_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712465/GSM712465_AUS2_177_p1569_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712640 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712466"	NA	"colorectal cancer sample AUS2_182_p1478 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_182_p1478 [gene-level]///geo_accession: GSM712466///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 1.49///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712466/GSM712466_AUS2_182_p1478_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712466/GSM712466_AUS2_182_p1478_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712641 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712467"	NA	"colorectal cancer sample AUS2_183_p1575 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_183_p1575 [gene-level]///geo_accession: GSM712467///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.9///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712467/GSM712467_AUS2_183_p1575_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712467/GSM712467_AUS2_183_p1575_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712642 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712468"	NA	"colorectal cancer sample AUS2_184_p1576 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-12"	NA	NA	NA	"title: colorectal cancer sample AUS2_184_p1576 [gene-level]///geo_accession: GSM712468///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712468/GSM712468_AUS2_184_p1576_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712468/GSM712468_AUS2_184_p1576_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712643 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712469"	NA	"colorectal cancer sample AUS2_185_p1577 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-12"	NA	NA	NA	"title: colorectal cancer sample AUS2_185_p1577 [gene-level]///geo_accession: GSM712469///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712469/GSM712469_AUS2_185_p1577_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712469/GSM712469_AUS2_185_p1577_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712644 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712470"	NA	"colorectal cancer sample AUS2_186_p1482 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-12"	NA	NA	NA	"title: colorectal cancer sample AUS2_186_p1482 [gene-level]///geo_accession: GSM712470///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.88///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712470/GSM712470_AUS2_186_p1482_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712470/GSM712470_AUS2_186_p1482_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712645 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712471"	NA	"colorectal cancer sample AUS2_187_p1579 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-12"	NA	NA	NA	"title: colorectal cancer sample AUS2_187_p1579 [gene-level]///geo_accession: GSM712471///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.5///characteristics_ch1.4: disease_free_survival_years: 1///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712471/GSM712471_AUS2_187_p1579_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712471/GSM712471_AUS2_187_p1579_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712646 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712472"	NA	"colorectal cancer sample AUS2_190_p1486 [gene-level]"	"tumor"	NA	NA	NA	"early"	"2"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_190_p1486 [gene-level]///geo_accession: GSM712472///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 2///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.84///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712472/GSM712472_AUS2_190_p1486_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712472/GSM712472_AUS2_190_p1486_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712647 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712473"	NA	"colorectal cancer sample AUS2_197_p1588 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_197_p1588 [gene-level]///geo_accession: GSM712473///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.76///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712473/GSM712473_AUS2_197_p1588_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712473/GSM712473_AUS2_197_p1588_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712648 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM712474"	NA	"colorectal cancer sample AUS2_200_p1591 [gene-level]"	"tumor"	NA	NA	NA	"late"	"3"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-18"	NA	NA	NA	"title: colorectal cancer sample AUS2_200_p1591 [gene-level]///geo_accession: GSM712474///status: Public on May 19 2011///submission_date: Apr 20 2011///last_update_date: Jul 01 2011///type: RNA///channel_count: 1///source_name_ch1: Colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: colorectal cancer biopsy///characteristics_ch1.1: tumor stage: 3///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: 2.75///characteristics_ch1.4: disease_free_survival_years: 0///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712474/GSM712474_AUS2_200_p1591_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM712nnn/GSM712474/GSM712474_AUS2_200_p1591_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: Alternative to: GSM712649 (exon-level)"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714419"	NA	"normal colonic mucosa sample AUS2_003_norm"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2008-06-20"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_003_norm///geo_accession: GSM714419///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714419/GSM714419_AUS2_003_norm_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714419/GSM714419_AUS2_003_norm_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714420"	NA	"normal colonic mucosa sample AUS2_012_norm"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2008-06-20"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_012_norm///geo_accession: GSM714420///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714420/GSM714420_AUS2_012_norm_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714420/GSM714420_AUS2_012_norm_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714421"	NA	"normal colonic mucosa sample AUS2_017_norm"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2008-07-10"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_017_norm///geo_accession: GSM714421///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714421/GSM714421_AUS2_017_norm_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714421/GSM714421_AUS2_017_norm_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714422"	NA	"normal colonic mucosa sample AUS2_029_norm"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2008-07-17"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_029_norm///geo_accession: GSM714422///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714422/GSM714422_AUS2_029_norm_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714422/GSM714422_AUS2_029_norm_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714423"	NA	"normal colonic mucosa sample AUS2_036_norm"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2008-07-17"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_036_norm///geo_accession: GSM714423///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714423/GSM714423_AUS2_036_norm_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714423/GSM714423_AUS2_036_norm_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714424"	NA	"normal colonic mucosa sample AUS2_038_p1961_NM"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-30"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_038_p1961_NM///geo_accession: GSM714424///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714424/GSM714424_AUS2_038_p1961_NM_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714424/GSM714424_AUS2_038_p1961_NM_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714425"	NA	"normal colonic mucosa sample AUS2_041_norm"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2008-07-17"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_041_norm///geo_accession: GSM714425///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714425/GSM714425_AUS2_041_norm_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714425/GSM714425_AUS2_041_norm_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714426"	NA	"normal colonic mucosa sample AUS2_044_p1962_NM"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-30"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_044_p1962_NM///geo_accession: GSM714426///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714426/GSM714426_AUS2_044_p1962_NM_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714426/GSM714426_AUS2_044_p1962_NM_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714427"	NA	"normal colonic mucosa sample AUS2_053_norm"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2008-07-17"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_053_norm///geo_accession: GSM714427///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714427/GSM714427_AUS2_053_norm_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714427/GSM714427_AUS2_053_norm_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714428"	NA	"normal colonic mucosa sample AUS2_054_norm"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2008-07-17"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_054_norm///geo_accession: GSM714428///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714428/GSM714428_AUS2_054_norm_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714428/GSM714428_AUS2_054_norm_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714429"	NA	"normal colonic mucosa sample AUS2_068_p1836_NM"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-25"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_068_p1836_NM///geo_accession: GSM714429///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714429/GSM714429_AUS2_068_p1836_NM_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714429/GSM714429_AUS2_068_p1836_NM_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714430"	NA	"normal colonic mucosa sample AUS2_072_p1965_NM"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-30"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_072_p1965_NM///geo_accession: GSM714430///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714430/GSM714430_AUS2_072_p1965_NM_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714430/GSM714430_AUS2_072_p1965_NM_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
"GSM714431"	NA	"normal colonic mucosa sample AUS2_100_p1840_NM"	"adjacentnormal"	NA	NA	NA	NA	"NA"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"n"	NA	NA	NA	NA	NA	NA	NA	"2010-03-25"	NA	NA	NA	"title: normal colonic mucosa sample AUS2_100_p1840_NM///geo_accession: GSM714431///status: Public on May 19 2011///submission_date: Apr 26 2011///last_update_date: Dec 04 2012///type: RNA///channel_count: 1///source_name_ch1: Normal colonic mucosa from colorectal cancer patient///organism_ch1: Homo sapiens///characteristics_ch1: tissue: normal colonic mucosa biopsy///characteristics_ch1.1: tumor stage: NA///characteristics_ch1.2: msi-status: NA///characteristics_ch1.3: disease_free_survival_event: NA///characteristics_ch1.4: disease_free_survival_years: NA///molecule_ch1: total RNA///extract_protocol_ch1: For the colorectal cancer samples, total RNA was isolated from <30 mg tissue biopsies using the AllPrep DNA/RNA Mini kit (Qiagen), according to the manufacturer's protocol. For the normal colon mucosa samples, total RNA was isolated from <100 mg tissue biopsies using the Ambion RiboPure kit (Life Technologies), according to the manufacturer's protocol.///label_ch1: biotin///label_protocol_ch1: Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).///taxid_ch1: 9606///hyb_protocol: Samples were hybridized with GeneChip Human Exon 1.0 ST Arrays (Affymetrix)///scan_protocol: Array scanning was performed according to the manufacturer's instruction (Affymetrix)///data_processing: For analysis at the exon level, raw data were processed (using a custom-made cdf-file; HuEx-1_0-st-v2,coreR3,A20071112,EP.cdf) and analyzed for alternative splicing with the FIRMA algorithm (aroma.affymetrix). For gene-level analysis, raw data were processed with the RMA procedure using Expression Console (Affymetrix; gene-core analysis).///platform_id: GPL5175///contact_name: Anita,,Sveen///contact_email: anita.sveen@rr-research.no///contact_department: Department of Cancer Prevention, Institute for Cancer Research///contact_institute: Oslo University Hospital, The Norwegian Radium Hospital///contact_address: P.O.Box 4953, Nydalen///contact_city: Oslo///contact_zip.postal_code: NO-0424///contact_country: Norway///contact_web_link: http://www.ous-research.no/cancerprevention////supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714431/GSM714431_AUS2_100_p1840_NM_HuEx-1_0-st-v2_.CEL.gz///supplementary_file.1: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM714nnn/GSM714431/GSM714431_AUS2_100_p1840_NM_HuEx-1_0-st-v2_.rma-gene-core.chp.gz///data_row_count: 22011///relation: "	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
